Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Active not recruiting 4Recruiting 3Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1NET 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 2Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumors 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Lung Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adrenal Gland Neoplasms 1

Interventions

Specimen Handling 477pembrolizumab 453Magnetic Resonance Spectroscopy 420Carboplatin 332Cyclophosphamide 311Cisplatin 273Biopsy 271Radiotherapy 245Paclitaxel 233Gemcitabine 228Bevacizumab 212Nivolumab 188fludarabine 184venetoclax 179Drug Therapy 170Dexamethasone 158Oxaliplatin 155Blood Specimen Collection 155Injections 153Capecitabine 151Fluorouracil 143Docetaxel 142Radiosurgery 133Standard of Care 132Rituximab 128Pemetrexed 123durvalumab 115atezolizumab 107Leucovorin 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × FAPI-46 × 1 year × Clear all
NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05518903 2025-10-02

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Mayo Clinic

Phase 2 Recruiting
130 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
30 enrolled
BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡